UpdatesGeneral Updates
Aakaar Medical's Q1 FY27 shows strong operational progress, with Xelix clinic network targeting 100 by H2 end.
Aakaar Medical Technologies LimitedAAKAAR · Filed with the exchange
FY27 revenue growth guided ~30%, EBITDA ~25%. Strengthening distribution and sales force initiatives are underway to enhance market reach and financial efficiency.
No comments yet. Be the first.